Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Yuanheng Pharmaceutical is a specialized pharmaceutical company located in the China Medical City (Taizhou), Jiangsu Province. Established in 2010, the firm focuses on the research, development, and manufacturing of high-quality chemical drugs across several therapeutic areas, including cardiovascular, gastroenterology, and infectious diseases. The company operates state-of-the-art production lines for tablets, capsules, and granules that meet national GMP standards. Its commercial portfolio features essential medications such as Amlodipine Besylate for hypertension and Rabeprazole Sodium for gastric disorders. By leveraging its location in a major biotech hub, Jiangsu Yuanheng Pharmaceutical continues to expand its manufacturing capabilities and product pipeline to serve the Chinese healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 江苏远恒药业.